<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD005940" GROUP_ID="PREG" ID="586805052414002048" MERGED_FROM="" MODIFIED="2010-05-11 15:41:44 +0200" MODIFIED_BY="Frances Kellie" NOTES="&lt;p&gt;Exported from Review Manager 4.2.9&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.7&lt;/p&gt;" NOTES_MODIFIED="2010-05-07 11:57:33 +0100" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="0340" REVMAN_SUB_VERSION="5.0.24" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="5.0">
<COVER_SHEET MODIFIED="2010-05-11 15:41:44 +0200" MODIFIED_BY="Frances Kellie">
<TITLE MODIFIED="2008-11-26 14:29:15 +0000" MODIFIED_BY="[Empty name]">Repeat digital cervical assessment in pregnancy for identifying women at risk of preterm labour</TITLE>
<CONTACT MODIFIED="2010-05-11 15:41:44 +0200" MODIFIED_BY="Frances Kellie"><PERSON ID="17681" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Sophie</FIRST_NAME><LAST_NAME>Alexander</LAST_NAME><EMAIL_1>salexand@ulb.ac.be</EMAIL_1><ADDRESS><DEPARTMENT>Perinatal Epidemiology and Reproductive Health Unit, School of Public Health</DEPARTMENT><ORGANISATION>Université Libre de Bruxelles</ORGANISATION><ADDRESS_1>808, Route de Lennik</ADDRESS_1><CITY>Brussels</CITY><ZIP>1070</ZIP><COUNTRY CODE="BE">Belgium</COUNTRY><PHONE_1>+32 2 5554063</PHONE_1><FAX_1>+32 2 5554049</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2010-05-11 15:41:44 +0200" MODIFIED_BY="Frances Kellie"><PERSON ID="17681" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Sophie</FIRST_NAME><LAST_NAME>Alexander</LAST_NAME><EMAIL_1>salexand@ulb.ac.be</EMAIL_1><ADDRESS><DEPARTMENT>Perinatal Epidemiology and Reproductive Health Unit, School of Public Health</DEPARTMENT><ORGANISATION>Université Libre de Bruxelles</ORGANISATION><ADDRESS_1>808, Route de Lennik</ADDRESS_1><CITY>Brussels</CITY><ZIP>1070</ZIP><COUNTRY CODE="BE">Belgium</COUNTRY><PHONE_1>+32 2 5554063</PHONE_1><FAX_1>+32 2 5554049</FAX_1></ADDRESS></PERSON><PERSON ID="5699" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Michel</FIRST_NAME><LAST_NAME>Boulvain</LAST_NAME><POSITION>Médecin adjoint agrégé</POSITION><EMAIL_1>michel.boulvain@hcuge.ch</EMAIL_1><ADDRESS><DEPARTMENT>Département de Gynécologie et d'Obstétrique, Unité de Développement en Obstétrique</DEPARTMENT><ORGANISATION>Maternité Hôpitaux Universitaires de Genève</ORGANISATION><ADDRESS_1>Boulevard de la Cluse, 32</ADDRESS_1><CITY>Genève 14</CITY><ZIP>CH-1211</ZIP><COUNTRY CODE="CH">Switzerland</COUNTRY><PHONE_1>+ 41 22 3824317</PHONE_1><FAX_1>+41 22 3824424</FAX_1><FAX_2>+41 22 3824165</FAX_2></ADDRESS></PERSON><PERSON ID="15857" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Gilles</FIRST_NAME><LAST_NAME>Ceysens</LAST_NAME><POSITION>Gynaecologist</POSITION><EMAIL_1>gceysens@ulb.ac.be</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>Ambroise Pare hospital</ORGANISATION><ADDRESS_1>Bd Kennedy, 2</ADDRESS_1><CITY>Mons</CITY><ZIP>7000</ZIP><COUNTRY CODE="BE">Belgium</COUNTRY><PHONE_1>003265393781</PHONE_1></ADDRESS></PERSON><PERSON ID="1137548782E26AA200492FF14202A470" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Edwige</FIRST_NAME><LAST_NAME>Haelterman</LAST_NAME><EMAIL_1>e.haelterman@immunehealth.eu</EMAIL_1><ADDRESS><DEPARTMENT>School of Public Health</DEPARTMENT><ORGANISATION>Université Libre de Bruxelles</ORGANISATION><ADDRESS_1>808, Route de Lennik</ADDRESS_1><CITY>Brussels</CITY><ZIP>1070</ZIP><COUNTRY CODE="BE">Belgium</COUNTRY><PHONE_1>+32 2 5554052</PHONE_1><FAX_1>+32 2 5554049</FAX_1></ADDRESS></PERSON><PERSON ID="113756D982E26AA200492FF1A504D27F" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Wei-Hong</FIRST_NAME><LAST_NAME>Zhang</LAST_NAME><EMAIL_1>wzhang@ulb.ac.be</EMAIL_1><ADDRESS><DEPARTMENT>Perinatal Epidemiology and Reproductive Health Unit, School of Public Health</DEPARTMENT><ORGANISATION>Université Libre de Bruxelles</ORGANISATION><ADDRESS_2>808, Route de Lennik</ADDRESS_2><CITY>Brussels</CITY><ZIP>1070</ZIP><COUNTRY CODE="BE">Belgium</COUNTRY><PHONE_1>+32 2 5556368</PHONE_1><FAX_1>+32 2 5554049</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2010-05-05 13:59:23 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Minor update: 17/02/06&lt;/p&gt;" NOTES_MODIFIED="2010-05-05 13:59:23 +0100" NOTES_MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="30" MONTH="3" YEAR="2010"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="30" MONTH="9" YEAR="2009"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="20" MONTH="3" YEAR="2012"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="2006"/>
<REVIEW_PUBLISHED ISSUE="" YEAR=""/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2006"/>
</DATES>
<WHATS_NEW MODIFIED="2008-11-26 14:04:26 +0000" MODIFIED_BY="[Empty name]"/>
<HISTORY MODIFIED="2008-11-26 14:04:43 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-11-26 14:04:43 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="23" MONTH="10" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2009-10-16 17:59:18 +0100" MODIFIED_BY="Gilles Ceysens">
<INTERNAL_SOURCES MODIFIED="2009-10-16 17:59:18 +0100" MODIFIED_BY="Gilles Ceysens">
<SOURCE MODIFIED="2009-10-16 17:59:18 +0100" MODIFIED_BY="Gilles Ceysens">
<NAME>Université Libre de Bruxelles (ULB) - School of Public Health</NAME>
<COUNTRY CODE="BE">Belgium</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2010-05-07 11:57:33 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2010-05-05 14:47:36 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2010-03-15 10:30:52 +0000" MODIFIED_BY="Gilles Ceysens">Repeat digital cervical assessment in pregnancy for identifying women at risk of preterm labour</TITLE>
<SUMMARY_BODY MODIFIED="2010-05-05 14:47:36 +0100" MODIFIED_BY="[Empty name]">
<P>Routine digital vaginal examination (examination of the cervix with a finger) during pregnancy, used to reduce the prevalence of preterm birth, is not supported by evidence from randomized controlled trials. Preterm labour is often preceded by changes in the cervix although the woman does not experience any symptoms. Effective detection and appropriate management of risk of preterm birth is key to improved care. Repeat digital cervical assessment is a simple inexpensive technique that uses a disposable glove and takes only one or two minutes to complete. It has been promoted as a routine intervention during pregnancy as a screening test for the risk of preterm birth (that is, birth occurring before 37 weeks of gestation), which can then be managed. It is in standard use in many parts of Europe, Africa and to a lesser extent in the US.</P>
<P>The review included two randomized controlled trials that enrolled a total of 7163 pregnant women. The number of women experiencing preterm birth was similar with and without routine digital vaginal examination when it was not medically indicated. One was a multicentre performed in countries where the intervention was routine and in countries where it was not. Causes for concern included the potential risk of infection and preterm labour from the vaginal examination as well as discomfort and embarrassment for the woman. We have found insufficient evidence to assess adverse effects of the intervention.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2010-05-05 14:54:11 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2009-11-05 10:42:49 +0000" MODIFIED_BY="[Empty name]">
<P>Repeat digital cervical assessment (RDCA - examination of the cervix with a finger) has been promoted as a routine intervention in the antenatal clinic as a screening test for the risk of preterm birth (that is, birth occurring before 37 weeks of gestation).</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To assess the effect of repeat digital cervical assessment during pregnancy for the risk of preterm birth and other adverse effects for mother and baby.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2010-05-05 11:36:16 +0100" MODIFIED_BY="Lynn Hampson">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (September 2009) and CENTRAL (<I>The Cochrane Library </I>2009, Issue <I>3</I>).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>All known randomized clinical trials comparing repeat digital cervical assessment with internal examination limited to clinical indication or no internal examination. We have not included studies where repeat cervical assessment is only a component of complex interventions targeted at decreasing preterm birth. </P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2010-05-05 09:08:39 +0100" MODIFIED_BY="[Empty name]">
<P>We evaluated relevant studies for meeting the inclusion criteria and methodological quality without considering their results. Three review authors extracted the data. For all data analyses, we entered data based on the principle of intention to treat. We calculated odds ratios and 95% confidence intervals for dichotomous data.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2010-05-05 14:54:11 +0100" MODIFIED_BY="[Empty name]">
<P>We included two trials that enrolled a total of 7163 women. Preterm birth before 37 weeks, was reported in both trials. The odds ratio for birth before 37 weeks was 1.05 (95% confidence interval 0.85 to 1.31; two trials, 6070 women). One trial (involving 5836 women) found no significant difference between the two treatment arms for the following outcomes: preterm birth before 34 weeks; preterm, prelabour rupture of membranes; hospital admission before 37 weeks; caesarean section; use of tocolytic drugs; low birthweight; very low birthweight, stillbirth, neonatal death, neonatal intensive care admissions; use of health services. The other prespecified outcomes were not evaluated in the included studies. We did not conduct the planned subgroup analyses due to insufficient data.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2010-04-20 12:46:28 +0100" MODIFIED_BY="[Empty name]">
<P>We found no evidence to support the use of RDCA in pregnancy to reduce the prevalence of preterm birth. We have found insufficient evidence to assess adverse effects of the intervention. </P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2010-05-07 10:04:30 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2010-05-05 09:04:37 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="2">Rationale for performing vaginal examination before term</HEADING>
<P>The main reason repeat digital cervical assessment (RDCA - examination of the cervix with a finger) has been promoted as a routine intervention in the antenatal clinic is as a screening test for the risk of preterm birth (that is, birth occurring before 37 weeks of gestation).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Preterm birth and treatment of threatened preterm labour</HEADING>
<P>Preterm birth occurs in around 5% to 10% of all pregnancies. Most neonatal deaths (up to 75%) will occur in this group. It is often suggested that effective detection and appropriate management of preterm risk is a key to improved perinatal outcome. Numerous interventions have been used, either for decreasing the risk of preterm birth or for the management of preterm labour. Some of these have been shown to be effective in Cochrane systematic reviews (screening and treating asymptomatic bacteriuria (<LINK REF="REF-Smaill-2001" TYPE="REFERENCE">Smaill 2001</LINK>)) and some tocolytics (medications intended to reduce uterine contractions), such as betamimetics (<LINK REF="REF-Anotayanonth-2004" TYPE="REFERENCE">Anotayanonth 2004</LINK>) and calcium channel blockers (<LINK REF="REF-King-2003" TYPE="REFERENCE">King 2003</LINK>). Others have not been proven useful, such as oxytocin receptor antagonists (<LINK REF="REF-Papatsonis-2005" TYPE="REFERENCE">Papatsonis 2005</LINK>), antibiotics (<LINK REF="REF-McDonald-2005" TYPE="REFERENCE">McDonald 2005</LINK>; <LINK REF="REF-Raynes_x002d_Greenow-2004" TYPE="REFERENCE">Raynes-Greenow 2004</LINK>), bed rest (<LINK REF="REF-Sosa-2004" TYPE="REFERENCE">Sosa 2004</LINK>) or magnesium sulphate (<LINK REF="REF-Crowther-2002" TYPE="REFERENCE">Crowther 2002</LINK>). Two major concerns remain, even with drugs which are effective: side effects, and the fact that they are only useful for a short time (48 hours), thereby allowing sufficient time to administer steroids to the mother for enhancement of fetal pulmonary maturation (<LINK REF="REF-Roberts-2006" TYPE="REFERENCE">Roberts 2006</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">RDCA as a screening test and the geographical distribution of its use</HEADING>
<P>Despite the lack of long-term effective treatment, screening for preterm birth remains an important activity in many parts of the Western world (<LINK REF="REF-Goffinet-2005" TYPE="REFERENCE">Goffinet 2005</LINK>). This attempt at screening includes diverse methods, such as risk scoring, RDCA, home monitoring (<LINK REF="REF-Brown-1999" TYPE="REFERENCE">Brown 1999</LINK>) or, more recently, cervical fibronectin (<LINK REF="REF-Honest-2002" TYPE="REFERENCE">Honest 2002</LINK>) and ultrasonographic assessment of the cervix (<LINK REF="REF-Berghella-2005" TYPE="REFERENCE">Berghella 2005</LINK>; <LINK REF="REF-Rust-2005" TYPE="REFERENCE">Rust 2005</LINK>). The fact that in normal-term birth the cervix will change before labour starts is the basis for the use of RDCA as screening test. Proponents of RDCA believe that preterm labour will also be regularly preceded by asymptomatic changes in cervical length, consistency, position or dilatation.</P>
<P>Digital cervical assessment or vaginal examination performed on repeated occasions at the antenatal clinic has been adopted at very different levels in the Western world. A <I>Lancet</I> editorial in 1988 (<LINK REF="REF-Anonymous-1988" TYPE="REFERENCE">Anonymous 1988</LINK>) dismissed it as being 'probably valueless' even on a single occasion.</P>
<P>On the other side of the channel, Emile Papiernik (<LINK REF="REF-Papiernik-1986" TYPE="REFERENCE">Papiernik 1986</LINK>; <LINK REF="REF-Papiernik-2004" TYPE="REFERENCE">Papiernik 2004</LINK>) introduced a technique for preventing preterm births which involves systematic screening (risk score and RDCA) offered to all pregnant women, leading the caregiver giving advice to make changes to the women's daily work pattern or lifestyle. This policy was evaluated by the French National Institute of Health (INSERM) and showed a progressive reduction from 8.6% to 5.4% in the rates of preterm births from 1972 to 1988 (<LINK REF="REF-Papiernik-1999" TYPE="REFERENCE">Papiernik 1999</LINK>). The reduction was not observed if a major risk factor was present, such as the history of a previous preterm birth or a late spontaneous abortion; not observed for twin pregnancies; and not observed for women who had an episode of bleeding during the index pregnancy. But a significant reduction of preterm births was observed for the women with middle-level risk factors, for example those related to hard, physically demanding jobs. The program involved many different interventions, with RDCA only a single component, hence it is unclear whether the reduction in preterm birth incidence was due to RDCA.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Performing RDCA and characteristics of the test</HEADING>
<P>RDCA is a simple technique using a disposable glove and takes only one or two minutes to complete. The assessment of the cervix is usually made according to the cervical criteria proposed by Bishop in 1964 (<LINK REF="REF-Bishop-1964" TYPE="REFERENCE">Bishop 1964</LINK>) involving cervical length, position, consistency and dilatation. In Germany, Belgium and France, it is usual to perform digital cervical assessment at each antenatal visit (<LINK REF="REF-Langer-1999" TYPE="REFERENCE">Langer 1999</LINK>). More recently, the cervix has also been assessed ultrasonographically. In the preterm setting this may provide some additional information beyond the digital examination, though there is some debate about this (<LINK REF="REF-Rozenberg-2004" TYPE="REFERENCE">Rozenberg 2004</LINK>). The ultrasound technique will not be included in this review as it is covered by another Cochrane review (<LINK REF="REF-Berghella-2009" TYPE="REFERENCE">Berghella 2009</LINK>).</P>
<P>The characteristics of RDCA as a test performed in average-risk pregnancies have been assessed in published studies. The fact that clinicians were not blinded means that some distortion of the predictive properties is possible. Notwithstanding this limitation, these studies show that there is an increased likelihood of preterm delivery in the presence of changes of the cervix (<LINK REF="REF-Blondel-1990" TYPE="REFERENCE">Blondel 1990</LINK>; <LINK REF="REF-Hartmann-1999" TYPE="REFERENCE">Hartmann 1999</LINK>). Similar predictive values (35% to 37% at 22 to 24 weeks) for fibronectin, ultrasonographic assessment and digital examination were observed by Iams (<LINK REF="REF-Iams-2002" TYPE="REFERENCE">Iams 2002</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Action on finding an abnormal digital cervical assessment</HEADING>
<P>The rationale for RDCA is that, in some pregnancies, the cervix will efface or dilate, or both, without the woman experiencing any symptoms; the detection by the care provider of asymptomatic cervical change should be followed by further action. These might include further testing, such as assessment of uterine activity with a cardiotocograph, fibronectin testing or ultrasonographic assessment of the cervix. Electromyography and cervical distensibility (cervicotonometer) are being researched. Some intervention will then be offered, starting with leave from work, decreased activity, oral treatment or even hospital admission and tocolytic drugs. French obstetricians report that the global package, which was introduced in the early 1970s and included routine repeat vaginal examination, was instrumental in decreasing preterm birth (<LINK REF="REF-Breart-1995" TYPE="REFERENCE">Breart 1995</LINK>). A randomized trial of this global intervention in the March of Dimes project in the US was not able to replicate the French success (<LINK REF="REF-Anonymous-1993" TYPE="REFERENCE">Anonymous 1993</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Possible risks and acceptability to women</HEADING>
<P>Causes for concern are multiple. They include the potential risk from the vaginal examination as well as discomfort and embarrassment for the woman. The main concern in relation to the pregnancy is that vaginal examination could, per se, increase the risk of preterm labour or preterm rupture of membranes either directly or by modification of the vaginal flora. The flora of the lower third of the vagina differs from that in the upper part, and contains more organisms from the perineum and rectum. The theoretical concern is that the digital examination might cause colonization of the upper part of the vagina with organisms from the lower part, and that these organisms in turn might cause infection. Observational studies suggest that once membranes are ruptured, digital examination will decrease the time lag to birth (<LINK REF="REF-Lewis-1992" TYPE="REFERENCE">Lewis 1992</LINK>), but that this is not the case with intact membranes (<LINK REF="REF-Holbrook-1987" TYPE="REFERENCE">Holbrook 1987</LINK>). No observational studies were found which showed poor outcomes in relation to RDCA.</P>
<P>Regarding women's personal feelings in relation to digital examination, these seem to vary. In the United Kingdom, vaginal examination is perceived as essentially different from other skin-to-skin examinations that a doctor might perform, such as abdominal palpation or inspection of the oropharynx. This presumably is the reason why 68% of male general practitioners (GPs) and 5% of female GPs offer a chaperone (<LINK REF="REF-Rosenthal-2005" TYPE="REFERENCE">Rosenthal 2005</LINK>). This does not seem to be the case in continental Europe, where chaperones are uncommon. No studies about women's perception of RDCA were found. The only case study we found was of women in labour from Hong Kong (<LINK REF="REF-Ying-2002" TYPE="REFERENCE">Ying 2002</LINK>) who reported that, providing they understood the potential benefit of the examination (in labour), they accepted it without difficulty.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">The systematic review</HEADING>
<P>In the context of geographical variation of practice, this review was conducted to address whether this method is useful to identify risk of preterm birth in time for effective interventions. It is important that, however inexpensive the test may be, it is not performed unless it proves to do more good than harm. This review did not explore trials of complex interventions targeted at decreasing preterm birth, in which RDCA was a component.</P>
</SUBSECTION>
</BACKGROUND>
<OBJECTIVES>
<P>To assess the effect of repeat digital cervical assessment during pregnancy for the risk of preterm birth and other adverse effects for mother and baby.</P>
</OBJECTIVES>
<METHODS MODIFIED="2010-05-07 10:04:30 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2010-05-05 09:04:37 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2010-05-05 09:04:37 +0100" MODIFIED_BY="[Empty name]">
<P>All known randomized clinical trials (RCTs) comparing repeat digital cervical assessment with internal examination limited to clinical indication or no internal examination. We have not included studies where repeat cervical assessment is only a component of complex interventions targeted at decreasing preterm birth. We have also included quasi-randomized trials.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>All pregnant women.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Repeat digital cervical assessment all through pregnancy.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2010-05-05 09:04:37 +0100" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2010-04-20 12:45:57 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Preterm birth</LI>
<LI>Preterm, prelabour rupture of membranes</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2010-05-05 09:04:37 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="5">Maternal outcomes</HEADING>
<OL>
<LI>Maternal satisfaction as defined by trial authors</LI>
<LI>Maternal anxiety as defined by trial authors</LI>
<LI>Chorioamnionitis</LI>
<LI>Hospital admission before 37 weeks</LI>
<LI>Use of health services (number of cardiotocographic recordings, number of ultrasounds)</LI>
<LI>Caesarean delivery</LI>
<LI>Vacuum or forceps delivery</LI>
<LI>Use of tocolytic drugs</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Fetal and neonatal outcomes</HEADING>
<OL>
<LI>Intrauterine growth restriction</LI>
<LI>Birthweight</LI>
<LI>Five-minute Apgar score less than seven</LI>
<LI>Umbilical arterial pH less than 7.2</LI>
<LI>Stillbirth</LI>
<LI>Neonatal infection*</LI>
<LI>Neonatal death</LI>
<LI>Neonatal intensive care unit admission</LI>
<LI>Ventilation</LI>
<LI>Hypoxic ischaemic encephalopathy</LI>
<LI>Respiratory distress syndrome</LI>
<LI>Length of stay in neonatal intensive care unit</LI>
</OL>
<P>* outcome not prespecified in the protocol.</P>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2010-05-05 11:37:00 +0100" MODIFIED_BY="Lynn Hampson">
<ELECTRONIC_SEARCHES MODIFIED="2010-05-05 11:37:00 +0100" MODIFIED_BY="Lynn Hampson">
<P>We searched the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register by contacting the Trials Search Co-ordinator (September 2009).</P>
<P>The Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register is maintained by the Trials Search Co-ordinator and contains trials identified from:</P>
<OL>
<LI>quarterly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>weekly searches of MEDLINE;</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts.</LI>
</OL>
<P>Details of the search strategies for CENTRAL and MEDLINE, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the &#8216;Specialized Register&#8217; section within the editorial information about the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html">Cochrane Pregnancy and Childbirth Group</A>.</P>
<P>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co-ordinator searches the register for each review using the topic list rather than keywords. </P>
<P>In addition, we searched CENTRAL (<I>The Cochrane Library </I>2009, Issue 3) using the search strategy listed in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2008-11-25 14:51:15 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the reference lists of relevant papers. </P>
<P>We did not apply any language restrictions.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2010-05-07 10:04:30 +0100" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2010-05-07 10:04:30 +0100" MODIFIED_BY="[Empty name]">
<P>Three review authors (Sophie Alexander, Weihong Zhang and Gilles Ceysens) independently assessed for inclusion all the potential studies we identified as a result of the search strategy. We resolved any disagreement through discussion.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2010-05-05 09:04:37 +0100" MODIFIED_BY="[Empty name]">
<P>We designed a form to extract data. For eligible studies, Gilles Ceysens extracted the data using the agreed form. We entered data into Review Manager software (<LINK REF="REF-RevMan-2008" TYPE="REFERENCE">RevMan 2008</LINK>) and checked for accuracy.</P>
<P>When information regarding any of the above was unclear, we attempted to contact authors of the original reports to provide further details.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2010-05-07 10:04:28 +0100" MODIFIED_BY="[Empty name]">
<P>Three review authors (Sophie Alexander, Weihong Zhang and Gilles Ceysens) independently assessed risk of bias for each study using the criteria outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>). We resolved any disagreement by discussion.</P>
<SUBSECTION>
<HEADING LEVEL="4">(1) Sequence generation (checking for possible selection bias)</HEADING>
<P>We describe for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups.</P>
<P>We assessed the method as:</P>
<UL>
<LI>adequate (any truly random process, e.g. random number table; computer random number generator);</LI>
<LI>inadequate (any non-random process, e.g. odd or even date of birth; hospital or clinic record number);</LI>
<LI>unclear.   </LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4"> (2) Allocation concealment (checking for possible selection bias)</HEADING>
<P>We describe for each included study the method used to conceal the allocation sequence in sufficient detail and determine whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>adequate (e.g. telephone or central randomization; consecutively numbered sealed opaque envelopes);</LI>
<LI>inadequate (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth);</LI>
<LI>unclear.   </LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3) Blinding (checking for possible performance bias)</HEADING>
<P>We describe for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We have judged studies at low risk of bias if they were blinded, or if we judged that the lack of blinding could not have affected the results. We have assessed blinding separately for different outcomes or classes of outcomes.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>adequate, inadequate or unclear for participants;</LI>
<LI>adequate, inadequate or unclear for personnel;</LI>
<LI>adequate, inadequate or unclear for outcome assessors.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(4) Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations)</HEADING>
<P>We describe for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We state whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with the total randomized participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we re-included missing data in the analyses which we undertook.</P>
<P>We assessed methods as:</P>
<UL>
<LI>adequate; 10% or less missing data;</LI>
<LI>inadequate; greater than 10% missing data;</LI>
<LI>unclear.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(5) Selective reporting bias</HEADING>
<P>We describe for each included study how we investigated the possibility of selective outcome reporting bias and what we found.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>adequate (where it was clear that all of the study&#8217;s prespecified outcomes and all expected outcomes of interest to the review have been reported);</LI>
<LI>inadequate (where not all the study&#8217;s prespecified outcomes have been reported; one or more reported primary outcomes were not prespecified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported);</LI>
<LI>unclear.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(6) Other sources of bias</HEADING>
<P>We describe for each included study any important concerns we have about other possible sources of bias.</P>
<P>We assessed whether each study was free of other problems that could put it at risk of bias:</P>
<UL>
<LI>yes;</LI>
<LI>no;</LI>
<LI>unclear.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(7) Overall risk of bias</HEADING>
<P>We made explicit judgements about whether studies are at high risk of bias, according to the criteria given in the <I>Handbook</I> (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we consider it is likely to impact on the findings.  We explored the impact of the level of bias through undertaking sensitivity analyses - <I>see </I>
<LINK TAG="SENSITIVITY_ANALYSIS" TYPE="SECTION">Sensitivity analysis</LINK>. </P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2010-05-05 09:04:37 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Dichotomous data</HEADING>
<P>For dichotomous data, we present results as odds ratio with 95% confidence intervals.<I> </I>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Continuous data</HEADING>
<P>For continuous data, we used the mean difference if outcomes are measured in the same way between trials. We used the standardized mean difference to combine trials that measure the same outcome, but use different methods. <B> </B>
</P>
</SUBSECTION>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2010-05-05 09:04:37 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Cluster-randomized trials</HEADING>
<P>If cluster-randomized trials are identified in subsequent updates of this review, we will include these in the analyses along with individually randomized trials. We will adjust their sample sizes<I> </I>using the methods described in the <I>Handbook</I> using an estimate of the intracluster correlation co-efficient (ICC) derived from the trial (if possible), or from another source (<LINK REF="REF-Donner-2001" TYPE="REFERENCE">Donner 2001</LINK>). If ICCs from other sources are used, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster-randomized trials and individually-randomized trials, we plan to synthesize the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomization unit is considered to be unlikely.</P>
<P>We will also acknowledge heterogeneity in the randomization unit and perform a separate meta-analysis.</P>
</SUBSECTION>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2010-05-05 09:12:54 +0100" MODIFIED_BY="[Empty name]">
<P>For included studies, we have noted levels of attrition. We have explored the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using <LINK TAG="SENSITIVITY_ANALYSIS" TYPE="SECTION">Sensitivity analysis</LINK>.</P>
<P>For all outcomes we have carried out analyses, as far as possible, on an intention-to-treat basis: i.e. we attempted to include all participants randomized to each group in the analyses. The denominator for each outcome in each trial was the number randomized minus any participants whose outcomes were known to be missing.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2010-05-05 09:13:05 +0100" MODIFIED_BY="[Empty name]">
<P>We used the I² statistic to measure heterogeneity among the trials in each analysis. If we identified substantial heterogeneity (I² greater than 50%), we explored it by prespecified subgroup analysis.<B> </B>
</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2010-05-05 09:04:37 +0100" MODIFIED_BY="[Empty name]">
<P>We were not able to contact Mortensen for further information on the lack of balance between the groups III and IV.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2010-05-05 09:18:34 +0100" MODIFIED_BY="[Empty name]">
<P>We carried out statistical analysis using the Review Manager software (<LINK REF="REF-RevMan-2008" TYPE="REFERENCE">RevMan 2008</LINK>). We used fixed-effect inverse variance meta-analysis for combining data where trials are examining the same intervention, and we judged the trials&#8217; populations and methods sufficiently similar. Where we suspected clinical or methodological heterogeneity between studies sufficient to suggest that treatment effects may differ between trials, we used random-effects meta-analysis.</P>
<P>If we identified substantial heterogeneity in a fixed-effect meta-analysis, we have noted this and repeated the analysis using a random-effects method.</P>
<P>We have not included outcomes where missing data are greater than 10% in the analysis.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2010-05-05 09:13:29 +0100" MODIFIED_BY="[Empty name]">
<P>In subsequent updates of this review, as data become available, we will carry out subgroup analyses by risk factors for preterm birth and will restrict the outcomes to primary outcomes alone.</P>
<P>For fixed-effect meta-analyses, we will conduct planned subgroup analyses classifying whole trials by interaction tests as described by <LINK REF="REF-Deeks-2001" TYPE="REFERENCE">Deeks 2001</LINK>. For random-effects meta-analyses, we will assess differences between subgroups by inspection of the subgroups&#8217; confidence intervals; non-overlapping confidence intervals indicate a statistically significant difference in treatment effect between the subgroups.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2010-05-05 09:04:37 +0100" MODIFIED_BY="[Empty name]">
<P>We have only included two trials; we performed sensitivity analysis, which did not change the results. In future updates, if additional data become available, we will perform sensitivity analyses where possible to assess the quality of included trials.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2010-05-05 14:51:18 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2010-05-05 14:48:33 +0100" MODIFIED_BY="[Empty name]">
<P>The search yielded five trials for consideration; we included two and excluded three. Referees identified two additional studies, but these did not meet our inclusion criteria as they were not RCTs (<LINK REF="REF-Leveno-1986" TYPE="REFERENCE">Leveno 1986</LINK>; <LINK REF="REF-Stubbs-1986" TYPE="REFERENCE">Stubbs 1986</LINK>).</P>
<INCLUDED_STUDIES_DESCR MODIFIED="2010-05-05 14:48:33 +0100" MODIFIED_BY="[Empty name]">
<P>Two trials, involving 7163 women, met the inclusion criteria. <LINK REF="STD-Buekens-1994" TYPE="STUDY">Buekens 1994</LINK> in a multicenter RCT included 2521 women in the intervention group and 2520 in the control group. <LINK REF="STD-Mortensen-1987" TYPE="STUDY">Mortensen 1987</LINK> allocated 1327 women into four groups. Women with obstetrical and/or gynaecological complications or in situations of physical and psychological stress in a previous pregnancy were allocated to group I. Group II consisted of women with complications during the first 24 weeks of gestation in the current pregnancy. The pregnancy was considered complicated in women with haemorrhage, urinary tract infections, painful contractions, or twins. The remainder were randomly divided into a cervically evaluated group (group III) and a control group without cervical screening (group IV). In group I, II and III, evaluation of the cervix was performed at weeks 24, 28 and 32. No cervical screening was done in group IV. We have only included in this review the women of group III (intervention, 581 women) and group IV (control 448 women) because women from the groups I and II were not randomized.</P>
<P>
<LINK REF="STD-Buekens-1994" TYPE="STUDY">Buekens 1994</LINK> included women before 20 weeks of pregnancy. The intervention was to attempt digital cervical examination at every prenatal visit and the controls were to avoid such examinations, except where medically indicated. <LINK REF="STD-Mortensen-1987" TYPE="STUDY">Mortensen 1987</LINK> included women at the first antenatal visit in the first trimester. <I>See</I> <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> for further details.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2010-05-05 09:14:20 +0100" MODIFIED_BY="[Empty name]">
<P>We excluded three trials (<LINK REF="STD-Jenniges-1990" TYPE="STUDY">Jenniges 1990</LINK>; <LINK REF="STD-Lenihan-1984" TYPE="STUDY">Lenihan 1984</LINK>; <LINK REF="STD-McDuffie-1992" TYPE="STUDY">McDuffie 1992</LINK>; <LINK REF="STD-Sivkin-1988" TYPE="STUDY">Sivkin 1988</LINK>) because the intervention started at 37 weeks of pregnancy. <I>See</I> <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> for further details.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]">
<P>We considered generation of the allocation sequence adequate in the trial by Buekens (<LINK REF="STD-Buekens-1994" TYPE="STUDY">Buekens 1994</LINK>) and inadequate in the study by Mortensen (<LINK REF="STD-Mortensen-1987" TYPE="STUDY">Mortensen 1987</LINK>), who used the date of birth. Nevertheless, we included the study because it was unlikely that it would introduce a bias in the outcomes evaluated. Additionally, there was 2.9% and 2.7% of miscarriage in the intervention and the control groups respectively.</P>
<ALLOCATION MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]">
<P>In <LINK REF="STD-Buekens-1994" TYPE="STUDY">Buekens 1994</LINK>, computer-generated randomization sets in individually sealed envelopes of thick paper were prepared for each centre at the central coordinating unit. <LINK REF="STD-Mortensen-1987" TYPE="STUDY">Mortensen 1987</LINK> "randomly divided in accordance to date of birth", a method which precludes allocation concealment.</P>
</ALLOCATION>
<BLINDING MODIFIED="2009-10-02 20:04:41 +0100" MODIFIED_BY="[Empty name]">
<P>In the context of type of intervention, blinding of the caregiver or the participant was not possible.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]">
<P>Both included studies included all outcome data because the losses to follow up were low. In the trial by <LINK REF="STD-Buekens-1994" TYPE="STUDY">Buekens 1994</LINK>, there were 4% losses to follow up in both groups. <LINK REF="STD-Mortensen-1987" TYPE="STUDY">Mortensen 1987</LINK> did not report losses to follow up.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]">
<P>We found no indication of selective reporting as required in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> version 5.0.1 (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>).</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="STD-Mortensen-1987" TYPE="STUDY">Mortensen 1987</LINK> had an imbalance in the number of women included in the two groups that was explained by the author by the design of the study. The women in the group "no cervical examination" were given "no special attention" (sic). It is thus possible that some preterm deliveries were not included. To evaluate this possibility, all medical records of preterm birth in the county during the study period were studied retrospectively.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2010-05-05 14:51:18 +0100" MODIFIED_BY="[Empty name]">
<P>The difference in preterm birth rate between the two included studies (2% in <LINK REF="STD-Mortensen-1987" TYPE="STUDY">Mortensen 1987</LINK> versus 6% in <LINK REF="STD-Buekens-1994" TYPE="STUDY">Buekens 1994</LINK>) is probably due to the design of the <LINK REF="STD-Mortensen-1987" TYPE="STUDY">Mortensen 1987</LINK> study, which randomized only low-risk women. We found no substantial heterogeneity. The only outcome that was reported in both trials was preterm birth before 37 weeks. The odds ratio for this outcome was 1.05 (95% confidence interval (CI) 0.85 to 1.31; 2 studies, 6070 women). There was no substantial heterogeneity.</P>
<P>Eleven other prespecified outcomes were evaluated in <LINK REF="STD-Buekens-1994" TYPE="STUDY">Buekens 1994</LINK> and there was no difference between the two arms: preterm birth at less than 34 weeks; preterm, prelabour premature rupture of the membranes; hospital admission before 37 weeks; caesarean deliveries; use of tocolytic drugs; low birthweight; very low birthweight; stillbirth; neonatal death; neonatal intensive care unit (NICU) admission; and use of health services.</P>
<P>The following prespecified outcomes were not reported in the included studies: maternal satisfaction; maternal anxiety; chorioamnionitis; vacuum or forceps delivery; intrauterine growth restriction; Apgar score less than seven at five minutes; ventilation; hypoxic ischaemic encephalopathy; respiratory distress syndrome; and length of stay in NICU.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]">
<P>We found no evidence to support the use of routine digital vaginal examination (RDCA - examination of the cervix with a finger) in pregnancy to reduce the prevalence of preterm birth. In fact, this intervention has not been in use in many parts of the world for many years. However, it is in standard use in many parts of Europe, Africa and to a lesser extent in the US. We have found insufficient evidence to assess adverse effects of the intervention.</P>
<P>All of the outcomes assessed but one (birth before 37 weeks) rely solely on one study (<LINK REF="STD-Buekens-1994" TYPE="STUDY">Buekens 1994</LINK>). The study was multicentric and performed in countries where the intervention was routine and in countries where it was not. In addition, prevalence of prematurity in countries which perform RDCA and those that do not, does not suggest any influence of this intervention (<LINK REF="REF-Buitendijk-2003" TYPE="REFERENCE">Buitendijk 2003</LINK>).</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]">
<P>The results from this systematic review show that routine digital cervical assessment in the absence of clinical indication is not useful. We have found insufficient evidence to assess adverse effects. Clinicians who are not performing RDCA should not change their practice, whereas those who perform it may consider modifying their practice.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]">
<P>Even though this review relies mainly on one trial, the results are considered to be robust. In addition, prevalence of prematurity among countries which perform RDCA and those which do not, does not suggest any influence of this intervention. As the studies included in this review have been conducted in high-income settings where the prevalence of complications is low, it might be useful to replicate the study in low-income settings where the prevalence of prematurity and complications is higher.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2010-05-05 09:03:53 +0100" MODIFIED_BY="[Empty name]">
<P>The authors acknowledge the assistance of the Pregnancy and Childbirth Review Group editorial base in the preparation of this review.</P>
<P>As part of the pre-publication editorial process, this review has been commented on by two peers (an editor and referee who is external to the editorial team), a member of the Pregnancy and Childbirth Group's international panel of consumers and the Group's Statistical Adviser.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2010-05-07 10:04:38 +0100" MODIFIED_BY="[Empty name]">
<P>Sophie Alexander was co-author of the <LINK REF="STD-Buekens-1994" TYPE="STUDY">Buekens 1994</LINK> included study. Trial assessment and data extraction for this trial was carried out independently by two members of the review team who were not involved in the study.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2010-05-07 11:57:33 +0100" MODIFIED_BY="[Empty name]">
<P>Sophie Alexander (SA) developed the idea and wrote the first draft of the protocol. SA, Gilles Ceysens (GS) and Wei-Hong Zhang (WHZ) worked collaboratively in the development of the protocol, performing a background literature search and making editorial amendments. SA, WHZ and GC independently assessed studies for inclusion and assessed trial quality. Gilles Ceysens performed data extraction. Michel Boulvain and Edwige Haelterman-Breinessen provided general advice on the protocol and the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]">
<P>The methods section has been updated in accordance with the Cochrane Pregnancy and Childbirth Group's updated methods. We have added 'neonatal infection' as a secondary outcome in response to referee comments and the editor's recommendation. We have added a quasi-randomized study because it was unlikely that it would introduce a bias in the outcomes evaluated.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2010-05-05 11:39:03 +0100" MODIFIED_BY="Lynn Hampson">
<STUDIES MODIFIED="2009-12-11 12:17:37 +0000" MODIFIED_BY="Gilles Ceysens">
<INCLUDED_STUDIES MODIFIED="2008-11-26 09:40:50 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Buekens-1994" MODIFIED="2008-11-26 09:40:50 +0000" MODIFIED_BY="[Empty name]" NAME="Buekens 1994" YEAR="1994">
<REFERENCE MODIFIED="2008-11-26 09:40:43 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="BOOK_SECTION">
<AU>Alexander S, Blondel B, Boutsen M, Buekens P</AU>
<TI>EC collaborative study on repeated vaginal examinations (REVE) during pregnancy</TI>
<SO>Evaluation in pre-, peri-, and post-natal care delivery systems</SO>
<YR>1992</YR>
<PG>11-39</PG>
<ED>Kaminski M</ED>
<PB>INSERM</PB>
<CY>Paris</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Buekens P, Alexander S, Boutsen M, Blondel B, Kaminski M, Reid M et al</AU>
<TI>Randomised controlled trial of routine cervical examinations in pregnancy</TI>
<SO>Lancet</SO>
<YR>1994</YR>
<VL>344</VL>
<PG>841-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-11-26 09:40:30 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Buekens P, Alexander S, Boutsen M</AU>
<TI>A randomized controlled trial on repeated vaginal examination during pregnancy</TI>
<SO>Proceedings of 3rd European Health Services Research Meeting; 1991 Dec 13-14; London, UK</SO>
<YR>1991</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-11-26 09:40:50 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Buekens P, Alexander S</AU>
<TI>Screening for risk factors in pregnancy: the routine vaginal examination</TI>
<SO>Proceedings of International Gynaecological Symposium; 1994 May 26-28; Bruges, Belgium</SO>
<YR>1994</YR>
<PG>1-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mortensen-1987" MODIFIED="2008-11-25 14:45:04 +0000" MODIFIED_BY="[Empty name]" NAME="Mortensen 1987" YEAR="1987">
<REFERENCE MODIFIED="2008-11-25 14:45:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mortensen OA, Franklin J, Lofstrand T, Svanberg B</AU>
<TI>Prediction of preterm birth</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>1987</YR>
<VL>66</VL>
<NO>6</NO>
<PG>507-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2009-12-11 12:17:37 +0000" MODIFIED_BY="Gilles Ceysens">
<STUDY DATA_SOURCE="PUB" ID="STD-Jenniges-1990" NAME="Jenniges 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jenniges K, Evans LR</AU>
<TI>Premature rupture of the membranes with routine cervical exams</TI>
<SO>Journal of Nurse Midwifery</SO>
<YR>1990</YR>
<VL>35</VL>
<PG>46-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lenihan-1984" NAME="Lenihan 1984" YEAR="1984">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lenihan JP</AU>
<TI>Relationship of antepartum pelvic examinations to premature rupture of the membranes</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1984</YR>
<VL>63</VL>
<PG>33-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McDuffie-1992" MODIFIED="2008-11-25 14:43:28 +0000" MODIFIED_BY="[Empty name]" NAME="McDuffie 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-11-25 14:43:28 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McDuffie R, Osborne L, Nelson G, Parke C, Crawmer S, Orleans M et al</AU>
<TI>Effect of routine weekly cervical exams at term on premature rupture of the membranes: a randomized controlled trial</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1991</YR>
<VL>164</VL>
<PG>306</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McDuffie RS, Nelson GE, Osborn CL, Parke CD, Crawmer SM, Orleans M et al</AU>
<TI>Effect of routine weekly cervical examinations at term on premature rupture of the membranes: a randomized controlled trial</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1992</YR>
<VL>79</VL>
<PG>219-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sivkin-1988" MODIFIED="2009-12-11 12:17:37 +0000" MODIFIED_BY="Gilles Ceysens" NAME="Sivkin 1988" YEAR="1988">
<REFERENCE MODIFIED="2009-12-11 12:17:37 +0000" MODIFIED_BY="Gilles Ceysens" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Sivkin M, Porte JA, Monheit AG, Stone ML</AU>
<TI>Relationship of antepartum pelvic examinations to the incidence of premature rupture of membranes, maternal infection, and cesarean delivery</TI>
<SO>Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2-5; Boston, Massachusetts, USA</SO>
<YR>1988</YR>
<PG>15</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2009-12-11 12:17:37 +0000" MODIFIED_BY="Gilles Ceysens">
<STUDY DATA_SOURCE="PUB" ID="STD-Crowther-1987" MODIFIED="2009-11-03 14:08:27 +0000" MODIFIED_BY="[Empty name]" NAME="Crowther 1987" YEAR="1987">
<REFERENCE MODIFIED="2009-11-03 14:08:27 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Crowther CA</AU>
<TI>Antepartum cervical assessments in the management of twin pregnancy</TI>
<SO>Personal communication</SO>
<YR>1987</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2010-05-05 11:39:03 +0100" MODIFIED_BY="Lynn Hampson">
<ADDITIONAL_REFERENCES MODIFIED="2010-05-05 11:39:03 +0100" MODIFIED_BY="Lynn Hampson">
<REFERENCE ID="REF-Anonymous-1988" NAME="Anonymous 1988" NOTES="&lt;p&gt;(25) Routine vaginal examination at antenatal booking. Lancet 1988; 2(8608):432-433.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Anonymous</AU>
<TI>Routine vaginal examination at antenatal booking</TI>
<SO>Lancet</SO>
<YR>1988</YR>
<VL>2</VL>
<NO>8608</NO>
<PG>432-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Anonymous-1993" NAME="Anonymous 1993" NOTES="&lt;p&gt;Multicenter randomized, controlled trial of a preterm birth prevention program. Collaborative Group on Preterm Birth Prevention. Am J Obstet Gynecol 1993; 169(2 Pt 1):352-366.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Anonymous</AU>
<TI>Multicenter randomized, controlled trial of a preterm birth prevention program. Collaborative Group on Preterm Birth Prevention</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1993</YR>
<VL>169</VL>
<NO>2 Pt 1</NO>
<PG>352-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Anotayanonth-2004" MODIFIED="2010-01-30 17:37:32 +0000" MODIFIED_BY="Gilles Ceysens" NAME="Anotayanonth 2004" NOTES="&lt;p&gt;(2) Anotayanonth S, Subhedar NV, Garner P, Neilson JP, Harigopal S. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2004;(4):CD004352.&lt;/p&gt;" NOTES_MODIFIED="2010-01-30 17:37:32 +0000" NOTES_MODIFIED_BY="Gilles Ceysens" TYPE="COCHRANE_REVIEW">
<AU>Anotayanonth S, Subhedar NV, Garner P, Neilson JP, Harigopal S</AU>
<TI>Betamimetics for inhibiting preterm labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2010-01-30 17:37:32 +0000" MODIFIED_BY="Gilles Ceysens">
<IDENTIFIER MODIFIED="2010-01-30 17:37:32 +0000" MODIFIED_BY="Gilles Ceysens" TYPE="DOI" VALUE="10.1002/14651858.CD004352.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Berghella-2005" NAME="Berghella 2005" NOTES="&lt;p&gt;(11) Berghella V, Odibo AO, To MS, Rust OA, Althuisius SM. Cerclage for Short Cervix on Ultrasonography: Meta-Analysis of Trials Using Individual Patient-Level Data. Obstet Gynecol 2005; 106(1):181-189.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Berghella V, Odibo AO, To MS, Rust OA, Althuisius SM</AU>
<TI>Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>2005</YR>
<VL>106</VL>
<NO>1</NO>
<PG>181-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Berghella-2009" MODIFIED="2010-05-05 09:05:01 +0100" MODIFIED_BY="[Empty name]" NAME="Berghella 2009" TYPE="COCHRANE_REVIEW">
<AU>Berghella V, Baxter JK, Hendrix NW</AU>
<TI>Cervical assessment by ultrasound for preventing preterm delivery</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2010-01-30 17:38:27 +0000" MODIFIED_BY="Gilles Ceysens">
<IDENTIFIER MODIFIED="2010-01-30 17:38:27 +0000" MODIFIED_BY="Gilles Ceysens" TYPE="DOI" VALUE="10.1002/14651858.CD007235.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bishop-1964" MODIFIED="2008-11-25 15:53:15 +0000" MODIFIED_BY="[Empty name]" NAME="Bishop 1964" NOTES="&lt;p&gt;(13) BISHOP EH. PELVIC SCORING FOR ELECTIVE INDUCTION. Obstet Gynecol 1964; 24:266-268.&lt;/p&gt;" NOTES_MODIFIED="2008-11-25 15:53:15 +0000" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Bishop EH</AU>
<TI>Pelvic scoring for elective induction</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1964</YR>
<VL>24</VL>
<PG>266-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Blondel-1990" NAME="Blondel 1990" NOTES="&lt;p&gt;(16) Blondel B, Le C, X, Kaminski M, Chavigny C, Breart G, Sureau C. Prediction of preterm delivery: is it substantially improved by routine vaginal examinations? Am J Obstet Gynecol 1990; 162(4):1042-1048.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Blondel B, Le Coutour X, Kaminski M, Chavigny C, Breart G, Sureau C</AU>
<TI>Prediction of preterm delivery: is it substantially improved by routine vaginal examinations?</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1990</YR>
<VL>162</VL>
<NO>4</NO>
<PG>1042-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Breart-1995" NAME="Breart 1995" NOTES="&lt;p&gt;(19) Breart G, Blondel B, Tuppin P, Grandjean H, Kaminski M. Did preterm deliveries continue to decrease in France in the 1980s? Paediatr Perinat Epidemiol 1995; 9(3):296-306.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Breart G, Blondel B, Tuppin P, Grandjean H, Kaminski M</AU>
<TI>Did preterm deliveries continue to decrease in France in the 1980s?</TI>
<SO>Paediatric and Perinatal Epidemiology</SO>
<YR>1995</YR>
<VL>9</VL>
<NO>3</NO>
<PG>296-306</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Brown-1999" NAME="Brown 1999" NOTES="&lt;p&gt;(9) Brown HL, Britton KA, Brizendine EJ, Hiett AK, Ingram D, Turnquest MA et al. A randomized comparison of home uterine activity monitoring in the outpatient management of women treated for preterm labor. Am J Obstet Gynecol 1999; 180(4):798-805.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Brown HL, Britton KA, Brizendine EJ, Hiett AK, Ingram D, Turnquest MA et al</AU>
<TI>A randomized comparison of home uterine activity monitoring in the outpatient management of women treated for preterm labor</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1999</YR>
<VL>180</VL>
<NO>4</NO>
<PG>798-805</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Buitendijk-2003" MODIFIED="2008-11-25 15:55:25 +0000" MODIFIED_BY="[Empty name]" NAME="Buitendijk 2003" TYPE="JOURNAL_ARTICLE">
<AU>Buitendijk S, Zeitlin J, Cuttini M, Langhoff-Roos J, Bottu J</AU>
<TI>Indicators of fetal and infant health outcomes</TI>
<SO>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</SO>
<YR>2003</YR>
<VL>111 Suppl 1</VL>
<PG>S66-77</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Crowther-2002" MODIFIED="2008-11-26 09:39:18 +0000" MODIFIED_BY="[Empty name]" NAME="Crowther 2002" NOTES="&lt;p&gt;(7) Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev 2002;(4):CD001060.&lt;/p&gt;" NOTES_MODIFIED="2008-11-26 09:39:18 +0000" NOTES_MODIFIED_BY="[Empty name]" TYPE="COCHRANE_REVIEW">
<AU>Crowther CA, Hiller JE, Doyle LW</AU>
<TI>Magnesium sulphate for preventing preterm birth in threatened preterm labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2002</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2008-11-25 15:35:21 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-11-25 15:35:21 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001060"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Deeks-2001" MODIFIED="2009-11-03 12:56:21 +0000" MODIFIED_BY="[Empty name]" NAME="Deeks 2001" NOTES="&lt;p&gt;Deeks JJ, Altman DG, Bradbury MJ. (2001) Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Systematic Reviews in Health Care: Meta-analysis in Context, eds M Egger, G Davey Smith, DG Altman. London; BMJ Books.&lt;/p&gt;" NOTES_MODIFIED="2009-11-03 12:56:21 +0000" NOTES_MODIFIED_BY="[Empty name]" TYPE="BOOK_SECTION">
<AU>Deeks JJ, Altman DG, Bradbury MJ</AU>
<TI>Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis</TI>
<SO>Systematic reviews in health care: meta-analysis in context</SO>
<YR>2001</YR>
<ED>M Egger, G Davey Smith, DG Altman</ED>
<PB>BMJ Books</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Donner-2001" MODIFIED="2008-11-25 15:39:03 +0000" MODIFIED_BY="[Empty name]" NAME="Donner 2001" TYPE="JOURNAL_ARTICLE">
<AU>Donner A, Piaggio G, Villar J</AU>
<TI>Statistical methods for the meta-analysis of cluster randomization trials</TI>
<SO>Statistical Methods in Medical Research</SO>
<YR>2001</YR>
<VL>10</VL>
<NO>5</NO>
<PG>425-38</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Goffinet-2005" MODIFIED="2010-05-05 09:06:38 +0100" MODIFIED_BY="[Empty name]" NAME="Goffinet 2005" TYPE="JOURNAL_ARTICLE">
<AU>Goffinet F</AU>
<TI>Primary predictors of preterm labour</TI>
<SO>BJOG: an international journal of obstetrics and gynaecology</SO>
<YR>2005</YR>
<VL>112 Suppl 1</VL>
<PG>38-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hartmann-1999" NAME="Hartmann 1999" NOTES="&lt;p&gt;(17) Hartmann K, Thorp JM, Jr., McDonald TL, Savitz DA, Granados JL. Cervical dimensions and risk of preterm birth: a prospective cohort study. Obstet Gynecol 1999; 93(4):504-509.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Hartmann K, Thorp JM Jr, McDonald TL, Savitz DA, Granados JL</AU>
<TI>Cervical dimensions and risk of preterm birth: a prospective cohort study</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1999</YR>
<VL>93</VL>
<NO>4</NO>
<PG>504-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2009-11-03 14:10:31 +0000" MODIFIED_BY="[Empty name]" NAME="Higgins 2008" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Holbrook-1987" NAME="Holbrook 1987" NOTES="&lt;p&gt;(22) Holbrook RH, Jr., Falcon J, Herron M, Lirette M, Laros RK, Jr., Creasy RK. Evaluation of the weekly cervical examination in a preterm birth prevention program. Am J Perinatol 1987; 4(3):240-244.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Holbrook RH Jr, Falcon J, Herron M, Lirette M, Laros RK Jr, Creasy RK</AU>
<TI>Evaluation of the weekly cervical examination in a preterm birth prevention program</TI>
<SO>American Journal of Perinatology</SO>
<YR>1987</YR>
<VL>4</VL>
<NO>3</NO>
<PG>240-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Honest-2002" NAME="Honest 2002" NOTES="&lt;p&gt;(10) Honest H, Bachmann LM, Gupta JK, Kleijnen J, Khan KS. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. BMJ 2002; 325(7359):301.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Honest H, Bachmann LM, Gupta JK, Kleijnen J, Khan KS</AU>
<TI>Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review</TI>
<SO>BMJ</SO>
<YR>2002</YR>
<VL>325</VL>
<NO>7359</NO>
<PG>301</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Iams-2002" NAME="Iams 2002" NOTES="&lt;p&gt;(18) Iams JD, Newman RB, Thom EA, Goldenberg RL, Mueller-Heubach E, Moawad A et al. Frequency of uterine contractions and the risk of spontaneous preterm delivery. N Engl J Med 2002; 346(4):250-255.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Iams JD, Newman RB, Thom EA, Goldenberg RL, Mueller-Heubach E, Moawad A et al</AU>
<TI>Frequency of uterine contractions and the risk of spontaneous preterm delivery</TI>
<SO>New England Journal of Medicine</SO>
<YR>2002</YR>
<VL>346</VL>
<NO>4</NO>
<PG>250-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-King-2003" MODIFIED="2008-11-26 09:43:08 +0000" MODIFIED_BY="[Empty name]" NAME="King 2003" NOTES="&lt;p&gt;(3) King JF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2003;(1):CD002255.&lt;/p&gt;" NOTES_MODIFIED="2008-11-26 09:43:08 +0000" NOTES_MODIFIED_BY="[Empty name]" TYPE="COCHRANE_REVIEW">
<AU>King JF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B</AU>
<TI>Calcium channel blockers for inhibiting preterm labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2008-11-25 15:45:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-11-25 15:45:34 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD002255"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Langer-1999" NAME="Langer 1999" NOTES="&lt;p&gt;(14) Langer B, Caneva MP, Schlaeder G. Routine prenatal care in Europe: the comparative experience of nine departments of gynaecology and obstetrics in eight different countries. Eur J Obstet Gynecol Reprod Biol 1999; 85(2):191-198.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Langer B, Caneva MP, Schlaeder G</AU>
<TI>Routine prenatal care in Europe: the comparative experience of nine departments of gynaecology and obstetrics in eight different countries</TI>
<SO>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</SO>
<YR>1999</YR>
<VL>85</VL>
<NO>2</NO>
<PG>191-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Leveno-1986" MODIFIED="2009-11-17 12:16:24 +0000" MODIFIED_BY="[Empty name]" NAME="Leveno 1986" TYPE="JOURNAL_ARTICLE">
<AU>Leveno KJ, Cox K, Roark ML</AU>
<TI>Cervical dilatation and prematurity revisited</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1986</YR>
<VL>68</VL>
<NO>3</NO>
<PG>434-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lewis-1992" NAME="Lewis 1992" NOTES="&lt;p&gt;(21) Lewis DF, Major CA, Towers CV, Asrat T, Harding JA, Garite TJ. Effects of digital vaginal examinations on latency period in preterm premature rupture of membranes. Obstet Gynecol 1992; 80(4):630-634.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Lewis DF, Major CA, Towers CV, Asrat T, Harding JA, Garite TJ</AU>
<TI>Effects of digital vaginal examinations on latency period in preterm premature rupture of membranes</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1992</YR>
<VL>80</VL>
<NO>4</NO>
<PG>630-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McDonald-2005" MODIFIED="2008-11-26 10:06:21 +0000" MODIFIED_BY="[Empty name]" NAME="McDonald 2005" NOTES="&lt;p&gt;(4) McDonald H, Brocklehurst P, Parsons J. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2005;(1):CD000262.&lt;/p&gt;" NOTES_MODIFIED="2008-11-26 10:06:21 +0000" NOTES_MODIFIED_BY="[Empty name]" TYPE="COCHRANE_REVIEW">
<AU>McDonald H, Brocklehurst P, Parsons J</AU>
<TI>Antibiotics for treating bacterial vaginosis in pregnancy</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2008-11-26 10:06:10 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-11-26 10:06:10 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="DOI: 10.1002/14651858.CD000262.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Papatsonis-2005" MODIFIED="2008-11-25 15:47:24 +0000" MODIFIED_BY="[Empty name]" NAME="Papatsonis 2005" TYPE="COCHRANE_REVIEW">
<AU>Papatsonis D, Flenady V, Cole S, Liley H</AU>
<TI>Oxytocin receptor antagonists for inhibiting preterm labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2008-11-25 15:47:24 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-11-25 15:47:24 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004452.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Papiernik-1986" NAME="Papiernik 1986" NOTES="&lt;p&gt;(12) Papiernik E, Bouyer J, Collin D, Winisdoerffer G, Dreyfus J. Precocious cervical ripening and preterm labor. Obstet Gynecol 1986; 67(2):238-242.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Papiernik E, Bouyer J, Collin D, Winisdoerffer G, Dreyfus J</AU>
<TI>Precocious cervical ripening and preterm labor</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1986</YR>
<VL>67</VL>
<NO>2</NO>
<PG>238-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Papiernik-1999" MODIFIED="2008-11-25 15:50:05 +0000" MODIFIED_BY="[Empty name]" NAME="Papiernik 1999" TYPE="JOURNAL_ARTICLE">
<AU>Papiernik E, Grange G</AU>
<TI>Prenatal screening with evaluated high risk scores</TI>
<SO>Journal of Perinatal Medicine</SO>
<YR>1999</YR>
<VL>27</VL>
<NO>1</NO>
<PG>21-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Papiernik-2004" NAME="Papiernik 2004" TYPE="JOURNAL_ARTICLE">
<AU>Papiernik E</AU>
<TI>Specialist life--Emile Papiernik</TI>
<SO>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</SO>
<YR>2004</YR>
<VL>117</VL>
<NO>2</NO>
<PG>255-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Raynes_x002d_Greenow-2004" MODIFIED="2008-11-25 15:49:15 +0000" MODIFIED_BY="[Empty name]" NAME="Raynes-Greenow 2004" NOTES="&lt;p&gt;(5) Raynes-Greenow CH, Roberts CL, Bell JC, Peat B, Gilbert GL. Antibiotics for ureaplasma in the vagina in pregnancy. Cochrane Database Syst Rev 2004;(1):CD003767.&lt;/p&gt;" NOTES_MODIFIED="2008-11-25 15:49:15 +0000" NOTES_MODIFIED_BY="[Empty name]" TYPE="COCHRANE_REVIEW">
<AU>Raynes-Greenow CH, Roberts CL, Bell JC, Peat B, Gilbert GL</AU>
<TI>Antibiotics for ureaplasma in the vagina in pregnancy</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2008-11-25 15:49:15 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-11-25 15:49:15 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003767.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2008" MODIFIED="2010-05-05 09:05:15 +0100" MODIFIED_BY="[Empty name]" NAME="RevMan 2008" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2008</YR>
<EN>5.0</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Roberts-2006" MODIFIED="2010-05-05 11:39:03 +0100" MODIFIED_BY="Lynn Hampson" NAME="Roberts 2006" TYPE="COCHRANE_REVIEW">
<AU>Roberts D, Dalziel SR</AU>
<TI>Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2010-03-15 10:56:45 +0000" MODIFIED_BY="Gilles Ceysens">
<IDENTIFIER MODIFIED="2010-03-15 10:56:45 +0000" MODIFIED_BY="Gilles Ceysens" TYPE="DOI" VALUE="10.1002/14651858.CD004454.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rosenthal-2005" NAME="Rosenthal 2005" NOTES="&lt;p&gt;(23) Rosenthal J, Rymer J, Jones R, Haldane S, Cohen S, Bartholomew J. Chaperones for intimate examinations: cross sectional survey of attitudes and practices of general practitioners. BMJ 2005; 330(7485):234-235.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Rosenthal J, Rymer J, Jones R, Haldane S, Cohen S, Bartholomew J</AU>
<TI>Chaperones for intimate examinations: cross sectional survey of attitudes and practices of general practitioners</TI>
<SO>BMJ</SO>
<YR>2005</YR>
<VL>330</VL>
<NO>7485</NO>
<PG>234-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rozenberg-2004" NAME="Rozenberg 2004" NOTES="&lt;p&gt;(15) Rozenberg P, Rudant J, Chevret S, Boulogne AI, Ville Y. Repeat measurement of cervical length after successful tocolysis. Obstet Gynecol 2004; 104(5 Pt 1):995-999.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Rozenberg P, Rudant J, Chevret S, Boulogne AI, Ville Y</AU>
<TI>Repeat measurement of cervical length after successful tocolysis</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>2004</YR>
<VL>104</VL>
<NO>5 Pt 1</NO>
<PG>995-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rust-2005" NAME="Rust 2005" NOTES="&lt;p&gt;Rust OA, Atlas RO, Kimmel S, Roberts WE, Hess LW. Does the presence of a funnel increase the risk of adverse perinatal outcome in a patient with a short cervix? Am J Obstet Gynecol 2005; 192(4):1060-1066.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Rust OA, Atlas RO, Kimmel S, Roberts WE, Hess LW</AU>
<TI>Does the presence of a funnel increase the risk of adverse perinatal outcome in a patient with a short cervix?</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2005</YR>
<VL>192</VL>
<NO>4</NO>
<PG>1060-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Smaill-2001" MODIFIED="2008-11-25 15:51:54 +0000" MODIFIED_BY="[Empty name]" NAME="Smaill 2001" NOTES="&lt;p&gt;(1) Smaill F. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2001;(2):CD000490.&lt;/p&gt;" NOTES_MODIFIED="2008-11-25 15:51:54 +0000" NOTES_MODIFIED_BY="[Empty name]" TYPE="COCHRANE_REVIEW">
<AU>Smaill F</AU>
<TI>Antibiotics for asymptomatic bacteriuria in pregnancy</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2008-11-25 15:51:52 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-11-25 15:51:52 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000490.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Sosa-2004" MODIFIED="2008-11-25 15:53:00 +0000" MODIFIED_BY="[Empty name]" NAME="Sosa 2004" NOTES="&lt;p&gt;(6) Sosa C, Althabe F, Belizan J, Bergel E. Bed rest in singleton pregnancies for preventing preterm birth. Cochrane Database Syst Rev 2004;(1):CD003581.&lt;/p&gt;" NOTES_MODIFIED="2008-11-25 15:53:00 +0000" NOTES_MODIFIED_BY="[Empty name]" TYPE="COCHRANE_REVIEW">
<AU>Sosa C, Althabe F, Belizan J, Bergel E</AU>
<TI>Bed rest in singleton pregnancies for preventing preterm birth</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2008-11-25 15:53:00 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-11-25 15:53:00 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003581.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Stubbs-1986" MODIFIED="2009-11-17 12:09:54 +0000" MODIFIED_BY="[Empty name]" NAME="Stubbs 1986" TYPE="JOURNAL_ARTICLE">
<AU>Stubbs TM, Van Dorsten JP, Miller MC 3rd</AU>
<TI>The preterm cervix and preterm labor: relative risks, predictive values, and change over time</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1986</YR>
<VL>155</VL>
<NO>4</NO>
<PG>829-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ying-2002" NAME="Ying 2002" NOTES="&lt;p&gt;(24) Ying LC, Levy V. Hong Kong Chinese women's experiences of vaginal examinations in labour. Midwifery 2002; 18(4):296-303.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Ying LC, Levy V</AU>
<TI>Hong Kong Chinese women's experiences of vaginal examinations in labour</TI>
<SO>Midwifery</SO>
<YR>2002</YR>
<VL>18</VL>
<NO>4</NO>
<PG>296-303</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES MODIFIED="2009-11-03 14:11:58 +0000" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2010-05-05 09:17:35 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2010-05-05 09:17:35 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2010-05-05 09:17:05 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Buekens-1994">
<CHAR_METHODS MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]">
<P>Multicenter randomized controlled trial.<BR/>Computer-generated randomization sets in individually sealed envelopes of thick paper were prepared for each centre at the central coordinating unit.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-05-05 09:16:49 +0100" MODIFIED_BY="[Empty name]">
<P>All women booked for prenatal care in seven European countries (Belgium, Denmark, Hungary, Ireland, Italy, Portugal, Spain). Reasons for exclusion (before randomization) were: booking after 20 weeks, patient refusal, or clinician's decision not to randomize for medical or other reasons. There was no consensus about medical contraindications to randomization, and the decision to exclude a woman on medical grounds was left to the clinician.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-10-16 15:04:42 +0100" MODIFIED_BY="Gilles Ceysens">
<P>To attempt digital cervical examination at every prenatal visit (intervention): 2920 women.<BR/>To avoid such examinations, except where medically indicated (control): 2916 women.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-05-05 09:17:05 +0100" MODIFIED_BY="[Empty name]">
<P>Preterm birth (before 37 weeks and before 34 weeks), preterm premature rupture of the membranes (before 37 weeks), hospital admission before 37 weeks, caesarean deliveries, use of tocolytic drugs, use of health services (number of cardiotocographic recordings; number of ultrasound), low birthweight (&lt; 2500 g), very low birth weight (&lt; 1500 g), stillbirth, early neonatal death, neonatal intensive care unit admission.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mortensen-1987">
<CHAR_METHODS MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]">
<P>Quasi-randomized controlled trial.<BR/>Allocation group was according to date of birth.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]">
<P>All women delivered in the county of Skaraborg in 1982 were recruited during 7 months (1526 women) at their first antenatal clinic in the first trimester. 199 were excluded as they subsequently moved to other areas, had a miscarriage or had an incomplete examination according to the protocol, leaving 1327 women. Women with obstetrical and/or gynaecological complications or in situations of physical and psychological stress in a previous pregnancy were allocated to group I. Group II consisted of women with complications during the first 24 weeks of gestation in the current pregnancy. The pregnancy was considered complicated in women with haemorrhage, urinary tract infections, painful contractions, or twins. The remainder were randomly divided into a cervically evaluated group (group III) and a control group without cervical screening (group IV). In group I, II and III, evaluation of the cervix was performed at weeks 24, 28 and 32 weeks. No cervical screening was done in group IV.</P>
<P>We have only included in this review the women of group III (intervention, 581 women) and group IV (control 448 women) because women from the groups I and II were not randomized.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-11-05 14:14:43 +0000" MODIFIED_BY="[Empty name]">
<P>Group 3: cervical screening.<BR/>Group 4: no cervical screening.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]">
<P>Preterm birth (&lt; 37 weeks).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2009-12-11 12:21:16 +0000" MODIFIED_BY="Gilles Ceysens" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2009-11-05 14:56:13 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jenniges-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 14:56:13 +0000" MODIFIED_BY="[Empty name]">
<P>The intervention started at 37 weeks of pregnancy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 14:56:16 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lenihan-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 14:56:16 +0000" MODIFIED_BY="[Empty name]">
<P>The intervention started at 37 weeks of pregnancy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 14:56:18 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McDuffie-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 14:56:18 +0000" MODIFIED_BY="[Empty name]">
<P>The intervention started at 37 weeks of pregnancy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-12-11 12:21:16 +0000" MODIFIED_BY="Gilles Ceysens" STUDY_ID="STD-Sivkin-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-12-11 12:21:16 +0000" MODIFIED_BY="Gilles Ceysens">
<P>The intervention started at 37 weeks of pregnancy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2009-12-11 12:17:37 +0000" MODIFIED_BY="Gilles Ceysens" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR STUDY_ID="STD-Crowther-1987">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2010-05-05 09:17:35 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2010-01-08 12:54:26 +0000" MODIFIED_BY="Gilles Ceysens" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-05 14:55:43 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buekens-1994">
<DESCRIPTION>
<P>Computer generated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-08 12:54:26 +0000" MODIFIED_BY="Gilles Ceysens" RESULT="UNKNOWN" STUDY_ID="STD-Mortensen-1987">
<DESCRIPTION>
<P>Randomization by date of birth.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buekens-1994">
<DESCRIPTION>
<P>Computer-generated randomization sets in individually sealed envelopes of thick paper were prepared for each centre at the central coordinating unit.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-04-20 12:38:03 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mortensen-1987">
<DESCRIPTION>
<P>No concealment of allocation possible when randomization by date of birth.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2009-11-05 14:55:44 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-11-05 14:55:44 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Buekens-1994">
<DESCRIPTION>
<P>Due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-11-05 14:15:12 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mortensen-1987">
<DESCRIPTION>
<P>Due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-11-05 14:14:20 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buekens-1994">
<DESCRIPTION>
<P>4% were lost to follow up in each group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mortensen-1987">
<DESCRIPTION>
<P>No losses to follow up were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2010-05-05 09:04:39 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buekens-1994">
<DESCRIPTION>
<P>We found no indication of selective reporting as required in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> version 5.0.1.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-05 09:04:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mortensen-1987">
<DESCRIPTION>
<P>We found no indication of selective reporting as required in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> version 5.0.1.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2010-05-05 09:17:35 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-05 09:04:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buekens-1994">
<DESCRIPTION>
<P>We found no indication of other bias as required in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> version 5.0.1.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-05-05 09:17:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mortensen-1987">
<DESCRIPTION>
<P>The imbalance between the 2 groups was justified by the author by the design of the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2010-05-05 09:18:02 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2010-05-05 09:18:02 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Systematic digital cervical examination versus no examination unless medically indicated</NAME>
<DICH_OUTCOME CHI2="0.002537725867226424" CI_END="1.3052138023087647" CI_START="0.846807177677302" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0513155645183538" ESTIMABLE="YES" EVENTS_1="181" EVENTS_2="170" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.11568165769539598" LOG_CI_START="-0.07221546948536768" LOG_EFFECT_SIZE="0.021733094105014155" METHOD="MH" MODIFIED="2010-05-04 17:41:44 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9598229012275584" P_Q="0.0" P_Z="0.6502622476118567" Q="0.0" RANDOM="NO" SCALE="4.08" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="3102" TOTAL_2="2968" WEIGHT="100.0" Z="0.4533979029649408">
<NAME>Preterm birth &lt; 37 weeks</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3161913482343608" CI_START="0.8421391786660539" EFFECT_SIZE="1.0528135167110322" ESTIMABLE="YES" EVENTS_1="169" EVENTS_2="161" LOG_CI_END="0.11931903171057705" LOG_CI_START="-0.0746161275839403" LOG_EFFECT_SIZE="0.022351452063318383" ORDER="15" O_E="0.0" SE="0.11391847256412059" STUDY_ID="STD-Buekens-1994" TOTAL_1="2521" TOTAL_2="2520" VAR="0.012977418391342295" WEIGHT="93.78654117728203"/>
<DICH_DATA CI_END="2.4632609298130657" CI_START="0.4296072109939396" EFFECT_SIZE="1.028705330990041" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="9" LOG_CI_END="0.39151041848783696" LOG_CI_START="-0.3669284375771368" LOG_EFFECT_SIZE="0.01229099045535011" ORDER="16" O_E="0.0" SE="0.44551073838545224" STUDY_ID="STD-Mortensen-1987" TOTAL_1="581" TOTAL_2="448" VAR="0.19847981801675088" WEIGHT="6.213458822717968"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.3438100980606844" CI_START="0.6471244241730223" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.9325300723866298" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="61" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.12833790027176614" LOG_CI_START="-0.18901220845565875" LOG_EFFECT_SIZE="-0.03033715409194632" METHOD="MH" MODIFIED="2010-05-04 17:41:57 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="0.707863968613943" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2521" TOTAL_2="2520" WEIGHT="100.0" Z="0.37472638438405115">
<NAME>Preterm birth &lt; 34 weeks</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3438100980606844" CI_START="0.6471244241730223" EFFECT_SIZE="0.9325300723866298" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="61" LOG_CI_END="0.12833790027176614" LOG_CI_START="-0.18901220845565875" LOG_EFFECT_SIZE="-0.03033715409194632" ORDER="17" O_E="0.0" SE="0.18641302477486285" STUDY_ID="STD-Buekens-1994" TOTAL_1="2521" TOTAL_2="2520" VAR="0.03474981580571363" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.1652205295169393" CI_START="0.9150150091489025" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0325668372925945" ESTIMABLE="YES" EVENTS_1="728" EVENTS_2="709" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.06640812766982478" LOG_CI_START="-0.03857178206788505" LOG_EFFECT_SIZE="0.013918172800969856" METHOD="MH" NO="3" P_CHI2="1.0" P_Q="0.0" P_Z="0.6032715219681084" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2686" TOTAL_2="2678" WEIGHT="100.0" Z="0.5197016741329309">
<NAME>Preterm premature rupture of the membranes</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1652205295169393" CI_START="0.9150150091489025" EFFECT_SIZE="1.0325668372925945" ESTIMABLE="YES" EVENTS_1="728" EVENTS_2="709" LOG_CI_END="0.06640812766982478" LOG_CI_START="-0.03857178206788505" LOG_EFFECT_SIZE="0.013918172800969856" ORDER="18" O_E="0.0" SE="0.0616657186388649" STUDY_ID="STD-Buekens-1994" TOTAL_1="2686" TOTAL_2="2678" VAR="0.00380266085524765" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2009-10-16 16:59:57 +0100" MODIFIED_BY="Gilles Ceysens" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Maternal satisfaction</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Maternal anxiety</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Chorioamniotitis</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.276322721804431" CI_START="0.995263628252851" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.127065917737127" ESTIMABLE="YES" EVENTS_1="685" EVENTS_2="626" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="0.10596050085685405" LOG_CI_START="-0.0020618668616856463" LOG_EFFECT_SIZE="0.0519493169975842" METHOD="MH" MODIFIED="2008-11-26 15:30:05 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Q="0.0" P_Z="0.05941057101917013" Q="0.0" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2719" TOTAL_2="2721" WEIGHT="100.0" Z="1.885142725292152">
<NAME>Hospital admission before 37 weeks</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.276322721804431" CI_START="0.995263628252851" EFFECT_SIZE="1.127065917737127" ESTIMABLE="YES" EVENTS_1="685" EVENTS_2="626" LOG_CI_END="0.10596050085685405" LOG_CI_START="-0.0020618668616856463" LOG_EFFECT_SIZE="0.0519493169975842" ORDER="20" O_E="0.0" SE="0.06345287351721429" STUDY_ID="STD-Buekens-1994" TOTAL_1="2719" TOTAL_2="2721" VAR="0.004026267157591594" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.2890941672890293" CI_START="0.9321418012883829" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.096183633852989" ESTIMABLE="YES" EVENTS_1="348" EVENTS_2="321" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="0.11028464337376201" LOG_CI_START="-0.030518015937152213" LOG_EFFECT_SIZE="0.03988331371830488" METHOD="MH" NO="8" P_CHI2="1.0" P_Q="0.0" P_Z="0.26684983086582936" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2683" TOTAL_2="2682" WEIGHT="100.0" Z="1.110346336561423">
<NAME>Caesarean deliveries</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2890941672890293" CI_START="0.9321418012883829" EFFECT_SIZE="1.096183633852989" ESTIMABLE="YES" EVENTS_1="348" EVENTS_2="321" LOG_CI_END="0.11028464337376201" LOG_CI_START="-0.030518015937152213" LOG_EFFECT_SIZE="0.03988331371830488" ORDER="21" O_E="0.0" SE="0.08270817906363541" STUDY_ID="STD-Buekens-1994" TOTAL_1="2683" TOTAL_2="2682" VAR="0.006840642884022378" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Vacuum/forceps</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.3142990186397225" CI_START="0.8865121409378008" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0794174525394478" ESTIMABLE="YES" EVENTS_1="223" EVENTS_2="208" I2="0.0" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="0.11869418361912493" LOG_CI_START="-0.05231531228394742" LOG_EFFECT_SIZE="0.03318943566758874" METHOD="MH" NO="10" P_CHI2="1.0" P_Q="0.0" P_Z="0.44678991066895823" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2719" TOTAL_2="2721" WEIGHT="100.0" Z="0.7607776191861675">
<NAME>Use of tocolytic drugs</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3142990186397225" CI_START="0.8865121409378008" EFFECT_SIZE="1.0794174525394478" ESTIMABLE="YES" EVENTS_1="223" EVENTS_2="208" LOG_CI_END="0.11869418361912493" LOG_CI_START="-0.05231531228394742" LOG_EFFECT_SIZE="0.03318943566758874" ORDER="22" O_E="0.0" SE="0.10045182440412176" STUDY_ID="STD-Buekens-1994" TOTAL_1="2719" TOTAL_2="2721" VAR="0.010090569026116512" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="11" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>IUGR</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.0439832183762805" CI_START="0.6881405688378606" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.8475890547609933" ESTIMABLE="YES" EVENTS_1="177" EVENTS_2="206" I2="0.0" I2_Q="0.0" ID="CMP-001.12" LOG_CI_END="0.01869351760766513" LOG_CI_START="-0.16232283787652965" LOG_EFFECT_SIZE="-0.07181466013443225" METHOD="MH" MODIFIED="2010-05-05 09:17:59 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="1.0" P_Q="0.0" P_Z="0.11990941575591181" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2688" TOTAL_2="2683" WEIGHT="100.00000000000001" Z="1.5551539201965794">
<NAME>Low birthweight</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.0439832183762805" CI_START="0.6881405688378606" EFFECT_SIZE="0.8475890547609933" ESTIMABLE="YES" EVENTS_1="177" EVENTS_2="206" LOG_CI_END="0.01869351760766513" LOG_CI_START="-0.16232283787652965" LOG_EFFECT_SIZE="-0.07181466013443225" ORDER="23" O_E="0.0" SE="0.10632990325682694" STUDY_ID="STD-Buekens-1994" TOTAL_1="2688" TOTAL_2="2683" VAR="0.011306048326606175" WEIGHT="100.00000000000001"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.237404746889972" CI_START="0.5278764460048235" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.808205926764817" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="48" I2="0.0" I2_Q="0.0" ID="CMP-001.13" LOG_CI_END="0.09251177771288688" LOG_CI_START="-0.2774677159083941" LOG_EFFECT_SIZE="-0.0924779690977536" METHOD="MH" MODIFIED="2010-05-05 09:18:02 +0100" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Q="0.0" P_Z="0.32718343729705945" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2688" TOTAL_2="2683" WEIGHT="100.0" Z="0.979802891349109">
<NAME>Very low birthweight</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.237404746889972" CI_START="0.5278764460048235" EFFECT_SIZE="0.808205926764817" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="48" LOG_CI_END="0.09251177771288688" LOG_CI_START="-0.2774677159083941" LOG_EFFECT_SIZE="-0.0924779690977536" ORDER="24" O_E="0.0" SE="0.21732778598117075" STUDY_ID="STD-Buekens-1994" TOTAL_1="2688" TOTAL_2="2683" VAR="0.04723136655947756" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.14" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-05-05 09:07:18 +0100" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Apgar score &lt; 7 at 5 minutes</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.15" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2008-11-26 15:30:56 +0000" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>pHa &lt; 7.20</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.9531122966892285" CI_START="0.6111197310220995" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0925133689839572" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="22" I2="0.0" I2_Q="0.0" ID="CMP-001.16" LOG_CI_END="0.2907272143223649" LOG_CI_START="-0.2138736941304677" LOG_EFFECT_SIZE="0.03842676009594863" METHOD="MH" NO="16" P_CHI2="1.0" P_Q="0.0" P_Z="0.7653113525187373" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2744" TOTAL_2="2746" WEIGHT="100.0" Z="0.2985133976930217">
<NAME>Stillbirth</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.9531122966892287" CI_START="0.6111197310220994" EFFECT_SIZE="1.0925133689839572" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="22" LOG_CI_END="0.290727214322365" LOG_CI_START="-0.21387369413046775" LOG_EFFECT_SIZE="0.03842676009594863" ORDER="25" O_E="0.0" SE="0.296405071439975" STUDY_ID="STD-Buekens-1994" TOTAL_1="2744" TOTAL_2="2746" VAR="0.08785596637533669" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.844840088539237" CI_START="0.7623231415161031" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.472646404744255" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="15" I2="0.0" I2_Q="0.0" ID="CMP-001.17" LOG_CI_END="0.45405785926646525" LOG_CI_START="-0.11786089633884972" LOG_EFFECT_SIZE="0.16809848146380774" METHOD="MH" NO="17" P_CHI2="1.0" P_Q="0.0" P_Z="0.24926107954468224" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2720" TOTAL_2="2724" WEIGHT="100.0" Z="1.1521460567462296">
<NAME>Neonatal death</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.844840088539237" CI_START="0.7623231415161031" EFFECT_SIZE="1.472646404744255" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="15" LOG_CI_END="0.45405785926646525" LOG_CI_START="-0.11786089633884972" LOG_EFFECT_SIZE="0.16809848146380774" ORDER="26" O_E="0.0" SE="0.33594790808606073" STUDY_ID="STD-Buekens-1994" TOTAL_1="2720" TOTAL_2="2724" VAR="0.11286099694740032" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.2747753797780517" CI_START="0.9274386167252078" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0873251192061681" ESTIMABLE="YES" EVENTS_1="362" EVENTS_2="338" I2="0.0" I2_Q="0.0" ID="CMP-001.18" LOG_CI_END="0.10543366718811789" LOG_CI_START="-0.032714824893195125" LOG_EFFECT_SIZE="0.0363594211474614" METHOD="MH" NO="18" P_CHI2="1.0" P_Q="0.0" P_Z="0.3022177373123148" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2659" TOTAL_2="2670" WEIGHT="100.0" Z="1.0316892334344625">
<NAME>NICU admission</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2747753797780517" CI_START="0.9274386167252078" EFFECT_SIZE="1.0873251192061681" ESTIMABLE="YES" EVENTS_1="362" EVENTS_2="338" LOG_CI_END="0.10543366718811789" LOG_CI_START="-0.032714824893195125" LOG_EFFECT_SIZE="0.0363594211474614" ORDER="27" O_E="0.0" SE="0.081149108094628" STUDY_ID="STD-Buekens-1994" TOTAL_1="2659" TOTAL_2="2670" VAR="0.006585177744553619" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.19" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="19" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Ventilation</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.20" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-05-05 09:07:38 +0100" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Hypoxic ischaemic encephalopathy</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.21" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="21" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Respiratory distress syndrome</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.22" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="22" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Length of stay in NICU</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.300164827849312" CI_START="0.9984446900450481" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.1393606402493812" ESTIMABLE="YES" EVENTS_1="2193" EVENTS_2="2137" I2="0.0" I2_Q="0.0" ID="CMP-001.23" LOG_CI_END="0.11399841329739352" LOG_CI_START="-6.75988353165803E-4" LOG_EFFECT_SIZE="0.05666121247211388" METHOD="MH" NO="23" P_CHI2="1.0" P_Q="0.0" P_Z="0.05276287506504949" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2719" TOTAL_2="2721" WEIGHT="100.0" Z="1.9368565986352069">
<NAME>Use of health services</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.300164827849312" CI_START="0.9984446900450481" EFFECT_SIZE="1.1393606402493812" ESTIMABLE="YES" EVENTS_1="2193" EVENTS_2="2137" LOG_CI_END="0.11399841329739352" LOG_CI_START="-6.75988353165803E-4" LOG_EFFECT_SIZE="0.05666121247211388" ORDER="28" O_E="0.0" SE="0.06736031117698162" STUDY_ID="STD-Buekens-1994" TOTAL_1="2719" TOTAL_2="2721" VAR="0.004537411521859795" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-11-25 14:52:03 +0000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2008-11-25 14:52:03 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-11-25 14:51:32 +0000" MODIFIED_BY="[Empty name]">CENTRAL search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-25 14:52:03 +0000" MODIFIED_BY="[Empty name]">
<P>#1 (cervi* near exam*) or (cervi* near assess*)<BR/>#2 digital near exam*<BR/>#3 vagina* near exam*<BR/>#4 pelvic near exam*<BR/>#5 pregnan* or antenatal* or prenatal* or antepart*<BR/>#6 (preterm or premature) near (labor or labour)<BR/>#7 pregnancy (explode MeSH)<BR/>#8 pregnancy complications (explode MeSH)<BR/>#9 (#1 or #2 or #3 or #4)<BR/>#10 (#5 or #6 or #7 or #8)<BR/>#11 (#9 and #10)</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>